In this video, Million Hearts® Executive Director Laurence Sperling, MD, overviews the 3 pillars of cardiovascular event prevention and how you can implement them into your practice.
In the future, will there be a stronger focus on precision medicine, population health, or both? In this video, Million Hearts® Executive Director Laurence Sperling, MD, provides his predictions and...
Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while...
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
In this video, Neal Birnbaum, MD, from Pacific Rheumatology Associates, talks about the challenges he has faced during the COVID-19 pandemic, including those associated with telemedicine and the...